[Establishment of a novel molecular-targeted therapy for hematological malignancies mediated through reactive oxygen species (ROS)].
Kizaki
Masahiro
M
D000970:Antineoplastic Agents / Q000378:metabolism; D017209:Apoptosis / Q000187:drug effects; D002211:Capsaicin / Q000494:pharmacology; D002392:Catechin / Q000031:analogs & derivatives / Q000494:pharmacology; D006706:Homeostasis; D006801:Humans; D007938:Leukemia / Q000473:pathology* / Q000628:therapy*; D008928:Mitochondria / Q000378:metabolism; D010084:Oxidation-Reduction; D018384:Oxidative Stress; D017382:Reactive Oxygen Species / Q000378:metabolism
D000970:Antineoplastic Agents; D017382:Reactive Oxygen Species; D002392:Catechin; C045651:epigallocatechin gallate; D002211:Capsaicin